OCEANIA: real-world study of ovarian cancer treatment patterns across multiple lines of therapy in Argentina and Brazil.
Future Oncol
; : 1-14, 2024 May 29.
Article
em En
| MEDLINE
| ID: mdl-38861309
ABSTRACT
Aim:
To evaluate real-world data on treatment patterns in Argentina and Brazil in patients with ovarian cancer.Methods:
This study evaluated de-identified antineoplastic exposure data from a private healthcare provider in Argentina and health claims database (Orizon) in Brazil from 2010 to 2019 and 2015 to 2020, respectively.Results:
Platinum-based chemotherapy was the most common first-line therapy (Argentina n =311 [87.6%]; Brazil n = 1142 [79.3%]). The proportion of patients receiving platinum-based chemotherapy declined across both populations from first- to second-line, while use of non-platinum-based, targeted, and hormone therapies increased. Duration of platinum-based treatment and time to next treatment decreased from first- to fourth-line.Conclusion:
There is an unmet need for effective therapies that can prolong time to next treatment in ovarian cancer in Argentina and Brazil.
[Box see text].
Texto completo:
1
Base de dados:
MEDLINE
País como assunto:
America do sul
/
Argentina
/
Brasil
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article